Inhibition of HDAC6 via Tubastatin-A prevents loss of tight junction proteins claudin-3 and ZO-1 and attenuates injury-induced tissue alterations, such as villous blunting, epithelial necrosis, and immune cell infiltration in a murine HS model (19). This evidence concerns the gene HDAC6 and histiocytic sarcoma.